| Literature DB >> 18577207 |
Cordula Tschuch1, Angela Schulz, Armin Pscherer, Wiebke Werft, Axel Benner, Agnes Hotz-Wagenblatt, Leticia Serra Barrionuevo, Peter Lichter, Daniel Mertens.
Abstract
BACKGROUND: Gene knock down by RNAi is a highly effective approach to silence gene expression in experimental as well as therapeutic settings. However, this widely used methodology entails serious pitfalls, especially concerning specificity of the RNAi molecules.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18577207 PMCID: PMC2443166 DOI: 10.1186/1471-2199-9-60
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Figure 1A siRNA directed against GFP specifically targets endogenous genes in human cells. (a) After transfection of the control siRNA directed against GFP, underrepresentation of the off-target genes CYLD and SOAT was detected by expression-microarrays 48 h post-transfection in HEK and HeLa cells. Normalization was performed as described in Additional file 5. (b) Verification of underrepresentation of CYLD and SOAT in HEK and HeLa cells by Real-Time PCR using the same mRNA as template. Expression of genes was normalized to the median of 2 housekeeping genes (PGK, DCTN2).
20 most significantly deregulated genes after transfection of GFP siRNA.
| 1 | NM_003101 | sterol O-acyltransferase activity | -2.28 | 8.72E-14 | 32.76 | -0.83 | 8.18E-07 | 14.15 | |
| 2 | Q96HQ8 | ~ | unknown | -1.95 | 8.72E-14 | 32.87 | -1.52 | 7.71E-12 | 27.43 |
| 3 | CASP8 | NM_033356 | signal transducer activity;caspase activity | -1.56 | 5.35E-13 | 30.32 | -0.88 | 6.42E-09 | 20.37 |
| 4 | C10orf56 | NM_153367 | nucleic acid binding;zinc ion binding | -1.62 | 6.03E-13 | 30.12 | -0.49 | 1.35E-05 | 10.51 |
| 5 | NUDT3 | NM_006703 | magnesium ion binding;hydrolase activity | -1.45 | 1.74E-12 | 28.78 | -0.42 | 6.64E-05 | 8.35 |
| 6 | RAB21 | NM_014999 | nucleotide binding;GTP binding | -1.55 | 1.89E-12 | 28.60 | -0.76 | 1.51E-07 | 16.52 |
| 7 | HMGCS1 | NM_002130 | hydroxymethylglutaryl-CoA synthase activity | -1.48 | 2.73E-12 | 28.09 | -0.45 | 6.05E-05 | 8.47 |
| 8 | PAICS | NM_006452 | catalytic activity;ATP binding | -1.37 | 3.72E-12 | 27.62 | -0.66 | 3.61E-07 | 15.39 |
| 9 | TM16F | NM_001025356 | integral to membrane | -1.59 | 4.96E-12 | 27.25 | -0.45 | 2.18E-04 | 6.68 |
| 10 | GOSR1 | NM_004871 | v-SNARE activity | -1.47 | 5.13E-12 | 27.13 | -0.46 | 6.89E-05 | 8.29 |
| 11 | PSF1 | NM_021067.3 | protein binding | -2.18 | 5.44E-12 | 27.01 | -1.55 | 5.47E-09 | 20.81 |
| 12 | NM_015247 | NFkB pathway | -1.39 | 6.75E-12 | 26.74 | -0.60 | 2.91E-06 | 12.56 | |
| 13 | CXorf34 | NM_024917 | methyltransferase activity | -1.68 | 1.11E-11 | 26.08 | -0.67 | 1.08E-05 | 10.82 |
| 14 | SKP2 | NM_005983 | protein binding | -1.18 | 1.80E-11 | 25.33 | -0.74 | 7.49E-08 | 17.28 |
| 15 | IL6ST | NM_002184 | interleukin-6 receptor activity;protein binding | -1.20 | 2.92E-11 | 24.72 | -0.57 | 3.49E-06 | 12.27 |
| 16 | C10orf119 | NM_024834 | hypothetical protein | -1.14 | 3.13E-11 | 24.63 | -0.26 | 5.18E-03 | 2.29 |
| 17 | LARS2 | NM_015340 | leucine-tRNA ligase activity;ATP binding | -1.18 | 5.29E-11 | 23.85 | -0.49 | 2.65E-05 | 9.59 |
| 18 | NR1D2 | NM_005126 | transcription factor activity | -1.12 | 5.63E-11 | 23.71 | -0.32 | 1.36E-03 | 4.11 |
| 19 | ACSL4 | NM_022977 | long-chain-fatty-acid-CoA ligase activity | -1.22 | 6.44E-11 | 23.51 | -0.47 | 7.21E-05 | 8.21 |
| 20 | CCD25 | NP_060716 | unknown | -1.09 | 1.72E-10 | 22.18 | -0.33 | 1.67E-03 | 3.83 |
| 1 | ANXA3 | NM_005139 | diphosphoinositol-polyphosphate phosphatase | 2.75 | 1.13E-15 | 37.54 | 0.47 | 3.89E-05 | 9.08 |
| 2 | LOC51149 | NM_016175 | hypothetical protein | 1.29 | 3.48E-11 | 24.46 | 0.29 | 8.79E-03 | 1.61 |
| 3 | DDAH1 | NM_012137 | hydrolase activity | 1.02 | 1.87E-10 | 22.07 | 0.35 | 5.88E-04 | 5.27 |
| 4 | UBP18 | NM_017414.2 | ubiquitin thiolesterase activity | 1.00 | 1.99E-10 | 21.99 | 0.54 | 4.64E-06 | 11.91 |
| 5 | IL15RA | NM_002189 | interleukin receptor activity | 1.01 | 2.06E-10 | 21.94 | 0.30 | 2.38E-03 | 3.34 |
| 6 | SPHK1 | NM_021972 | calmodulin binding;transferase activity | 1.01 | 2.16E-10 | 21.88 | 0.42 | 9.44E-05 | 7.85 |
| 7 | HIST1H2AC | NM_003512.3 | DNA binding | 1.27 | 2.49E-10 | 21.68 | 0.54 | 7.94E-05 | 8.08 |
| 8 | MAG1 | NM_032717 | acyltransferase activity | 0.95 | 2.70E-10 | 21.53 | 0.40 | 1.21E-04 | 7.53 |
| 9 | SAT1 | NM_002970 | acyltransferase activity | 1.08 | 3.21E-10 | 21.24 | 0.45 | 1.46E-04 | 7.25 |
| 10 | PTGS2 | NM_000963 | peroxidase activity;oxidoreductase activity | 1.25 | 4.65E-10 | 20.78 | 0.38 | 3.44E-03 | 2.84 |
| 11 | HDHD1A | NM_012080 | catalytic activity | 0.95 | 8.31E-10 | 20.03 | 0.35 | 8.84E-04 | 4.67 |
| 12 | STAMBPL1 | NM_020799 | ubiquitin thiolesterase activity | 0.80 | 9.32E-10 | 19.90 | 0.30 | 8.23E-04 | 4.78 |
| 13 | PIGL | NM_004278 | hydrolase activity | 0.83 | 1.17E-09 | 19.61 | 0.36 | 2.10E-04 | 6.73 |
| 14 | CLPB | NM_030813 | nucleoside-triphosphatase activity | 0.81 | 2.28E-09 | 18.74 | 0.28 | 3.67E-03 | 2.75 |
| 15 | SMPDL3B | NM_014474 | hydrolase activity, acting on glycosyl bonds | 0.88 | 2.40E-09 | 18.67 | 0.33 | 1.45E-03 | 4.02 |
| 16 | HERC6 | NM_017912 | ubiquitin-protein ligase activity;GEF activity | 0.81 | 2.69E-09 | 18.52 | 0.43 | 5.32E-05 | 8.62 |
| 17 | GLRB | NM_000824 | inhibitory glycine receptor,CNS | 0.79 | 4.31E-09 | 17.90 | 0.28 | 3.47E-03 | 2.82 |
| 18 | HHLA3 | NM_007071 | unknown | 0.73 | 5.02E-09 | 17.71 | 0.36 | 1.86E-04 | 6.89 |
| 19 | GNPDA1 | NM_005471 | hydrolase activity | 0.63 | 2.46E-08 | 15.68 | 0.36 | 1.54E-04 | 7.17 |
| 20 | PLEKHA7 | NM_175058 | unknown | 0.63 | 3.29E-08 | 15.32 | 0.28 | 1.97E-03 | 3.59 |
X log2 expression ratio, § adjusted p value, S B statistics (for details see Methods and Additional file 5)
Sequences of the most commonly used control siRNA against GFP
| Ambion | siRNA | GFP/eGFP | |
| Qiagen | siRNA | GFP/eGFP | |
| Dharmacon | siRNA | GFP I | G |
Figure 2Off-target effects recur in 3/4 different cell lines and are independent of preparation protocols. (a) After transfection of the siRNA directed against GFP, expression of the genes CYLD and SOAT was measured with qPCR in different cell lines after 48 h. As negative controls, a siRNA directed against a candidate tumour supressor gene (siRNA1) was transfected and a mock transfection was performed. Values are normalized to mock and the median of 2 housekeeping genes. (b) 2 different siRNA molecules with the same target sequence but of different methodological origin were transfected, one generated by in vitro transcription (see Methods) and a second siRNA was obtained by oligonucleotide synthesis (Table 1). After transfection, the expression of CYLD and SOAT was measured in HEK and HeLa cells and normalized expression after mock transfection and the median of 2 housekeeping genes (PGK, DCTN2).
Figure 3Degree of off-target knock down of CYLD and SOAT correlates with the concentration of the transfected siRNA. (a) Different concentrations of the siRNA directed against GFP were transfected in HeLa and (b) HEK cells. Expression of specific off-target genes (CYLD, SOAT), non-target genes used as negative control (LMNB1, C13ORF1) and genes unspecifically upregulated by antiviral cellular response (OAS1) were measured by qPCR 48 h post-transfection. Expression values were normalized to the average of 2 housekeeping genes (PGK, DCTN2). Correlation coefficients between the amount of siRNA transfected and the corresponding mRNA levels of the genes measured are given.
Figure 4mRNAs deregulated by GFP siRNA contain short sequences perfectly matched to the sense or antisense strand of GFP siRNA. In order to shed light on the molecular mechanism of sequence-specific off-target effects, we analyzed the mRNAs modulated after transfection of GFP siRNA for sequence homology to the transfected siRNA molecules. The number of perfect matches with a homology length of at least 8 bp was significantly higher using the proper GFP siRNA sequences as compared to the shuffled siRNA sequences.